ロード中...
Metformin as a new anti-cancer drug in adrenocortical carcinoma
Adrenocortical carcinoma (ACC) is a rare heterogeneous malignancy with poor prognosis. Since radical surgery is the only available treatment, more specific and effective drugs are urgently required. The anti-diabetic drug metformin has been associated with a decreased cancer prevalence and mortality...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5226535/ https://ncbi.nlm.nih.gov/pubmed/27391065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10421 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|